223 related articles for article (PubMed ID: 7996439)
1. Antinociceptive actions of dexmedetomidine and the kappa-opioid agonist U-50,488H against noxious thermal, mechanical and inflammatory stimuli.
Idänpään-Heikkilä JJ; Kalso EA; Seppälä T
J Pharmacol Exp Ther; 1994 Dec; 271(3):1306-13. PubMed ID: 7996439
[TBL] [Abstract][Full Text] [Related]
2. Modulatory role of ginsenosides injected intrathecally or intracerebroventricularly in the production of antinociception induced by kappa-opioid receptor agonist administered intracerebroventricularly in the mouse.
Suh HW; Song DK; Huh SO; Kim YH
Planta Med; 2000 Jun; 66(5):412-7. PubMed ID: 10909259
[TBL] [Abstract][Full Text] [Related]
3. Contralateral, ipsilateral and bilateral treatments with the kappa-opioid receptor agonist U-50,488H in mononeuropathic rats.
Bileviciute-Ljungar I; Spetea M
Eur J Pharmacol; 2004 Jun; 494(2-3):139-46. PubMed ID: 15212967
[TBL] [Abstract][Full Text] [Related]
4. Differences in the antinociceptive effects of alpha-2 adrenoceptor agonists in two substrains of Sprague-Dawley rats.
Graham BA; Hammond DL; Proudfit HK
J Pharmacol Exp Ther; 1997 Nov; 283(2):511-9. PubMed ID: 9353364
[TBL] [Abstract][Full Text] [Related]
5. Anti-inflammatory effects of contralateral administration of the kappa-opioid agonist U-50,488H in rats with unilaterally induced adjuvant arthritis.
Bileviciute-Ljungar I; Saxne T; Spetea M
Rheumatology (Oxford); 2006 Mar; 45(3):295-302. PubMed ID: 16249243
[TBL] [Abstract][Full Text] [Related]
6. Contralateral but not systemic administration of the kappa-opioid agonist U-50,488H induces anti-nociception in acute hindpaw inflammation in rats.
Bileviciute-Ljungar I; Spetea M
Br J Pharmacol; 2001 Jan; 132(1):252-8. PubMed ID: 11156584
[TBL] [Abstract][Full Text] [Related]
7. Chronic muscle pain induced by repeated acid Injection is reversed by spinally administered mu- and delta-, but not kappa-, opioid receptor agonists.
Sluka KA; Rohlwing JJ; Bussey RA; Eikenberry SA; Wilken JM
J Pharmacol Exp Ther; 2002 Sep; 302(3):1146-50. PubMed ID: 12183674
[TBL] [Abstract][Full Text] [Related]
8. Functional interaction among opioid receptor types: up-regulation of mu- and delta-opioid receptor functions after repeated stimulation of kappa-opioid receptors.
Khotib J; Narita M; Suzuki M; Yajima Y; Suzuki T
Neuropharmacology; 2004 Mar; 46(4):531-40. PubMed ID: 14975677
[TBL] [Abstract][Full Text] [Related]
9. Delta-1 opioid receptor-mediated antinociceptive properties of a nonpeptidic delta opioid receptor agonist, (-)TAN-67, in the mouse spinal cord.
Tseng LF; Narita M; Mizoguchi H; Kawai K; Mizusuna A; Kamei J; Suzuki T; Nagase H
J Pharmacol Exp Ther; 1997 Feb; 280(2):600-5. PubMed ID: 9023269
[TBL] [Abstract][Full Text] [Related]
10. beta-Endorphin-like immunoreactivity in discrete brain regions, spinal cord, pituitary gland and peripheral tissues of U-50,488H-tolerant and -abstinent rats.
Bhargava HN; Matwyshyn GA; Rattan AK; Koo KL; Tejwani GA
J Pharmacol Exp Ther; 1994 Feb; 268(2):856-61. PubMed ID: 8113998
[TBL] [Abstract][Full Text] [Related]
11. Effects of U-50,488H on scopolamine-, mecamylamine- and dizocilpine-induced learning and memory impairment in rats.
Hiramatsu M; Murasawa H; Nabeshima T; Kameyama T
J Pharmacol Exp Ther; 1998 Mar; 284(3):858-67. PubMed ID: 9495843
[TBL] [Abstract][Full Text] [Related]
12. Peripherally mediated antinociception of the mu-opioid receptor agonist 2-[(4,5alpha-epoxy-3-hydroxy-14beta-methoxy-17-methylmorphinan-6beta-yl)amino]acetic acid (HS-731) after subcutaneous and oral administration in rats with carrageenan-induced hindpaw inflammation.
Bileviciute-Ljungar I; Spetea M; Guo Y; Schütz J; Windisch P; Schmidhammer H
J Pharmacol Exp Ther; 2006 Apr; 317(1):220-7. PubMed ID: 16339394
[TBL] [Abstract][Full Text] [Related]
13. Induction of bladder sphincter dyssynergia by kappa-2 opioid receptor agonists in the female rat.
Gu B; Fraser MO; Thor KB; Dolber PC
J Urol; 2004 Jan; 171(1):472-7. PubMed ID: 14665958
[TBL] [Abstract][Full Text] [Related]
14. Role of the nitric oxide pathway in kappa-opioid-induced hypothermia in rats.
Benamar K; Geller EB; Adler MW
J Pharmacol Exp Ther; 2002 Oct; 303(1):375-8. PubMed ID: 12235273
[TBL] [Abstract][Full Text] [Related]
15. Characterization of the antinociceptive effect of oxycodone in male and female rats.
Holtman JR; Wala EP
Pharmacol Biochem Behav; 2006 Jan; 83(1):100-8. PubMed ID: 16434089
[TBL] [Abstract][Full Text] [Related]
16. To what extent do spinal interactions between an alpha-2 adrenoceptor agonist and a mu opioid agonist influence noxiously evoked c-Fos expression in the rat? A pharmacological study.
Honoré P; Chapman V; Buritova J; Besson JM
J Pharmacol Exp Ther; 1996 Jul; 278(1):393-403. PubMed ID: 8764375
[TBL] [Abstract][Full Text] [Related]
17. Dose-dependent antagonism and potentiation of nitrous oxide antinociception by naloxone in mice.
Quock RM; Curtis BA; Reynolds BJ; Mueller JL
J Pharmacol Exp Ther; 1993 Oct; 267(1):117-22. PubMed ID: 8229738
[TBL] [Abstract][Full Text] [Related]
18. Pretreatment with pertussis toxin differentially modulates morphine- and beta-endorphin-induced antinociception in the mouse.
Tseng LF; Collins KA
J Pharmacol Exp Ther; 1996 Oct; 279(1):39-46. PubMed ID: 8858973
[TBL] [Abstract][Full Text] [Related]
19. Interactions of NMDA antagonists and an alpha 2 agonist with mu, delta and kappa opioids in an acute nociception assay.
Baker AK; Hoffmann VL; Meert TF
Acta Anaesthesiol Belg; 2002; 53(3):203-12. PubMed ID: 12461830
[TBL] [Abstract][Full Text] [Related]
20. Involvement of kappa-opioid receptors and sigma receptors in memory function demonstrated using an antisense strategy.
Hiramatsu M; Hoshino T
Brain Res; 2004 Dec; 1030(2):247-55. PubMed ID: 15571673
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
